Patents by Inventor Junn Yanagisawa

Junn Yanagisawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for screening a substance which can suppress degradation of a nuclear receptor or a substance which can promote degradation of a nuclear receptor
    Publication number: 20050186587
    Abstract: A method is provided for screening a substance which can suppress or promote degradation of a nuclear receptor, comprising the steps of: judging whether or not a test substance can suppress or promote binding of a CHIP with a nuclear receptor via a chaperone protein; and screening a test substance which can suppress the binding as a substance which can suppress degradation of a nuclear receptor or screening a test substance which can promote the binding as a substance which can promote degradation of a nuclear receptor.
    Type: Application
    Filed: August 25, 2004
    Publication date: August 25, 2005
    Applicant: Interite, Inc.
    Inventors: Junn Yanagisawa, Yukiyo Tateishi
  • Compounds that inhibit the interaction between signal-transducing proteins and the GLGF (PDZ/DHR) domain and uses thereof
    Patent number: 6911526
    Abstract: This invention provides for a composition capable of inhibiting specific binding between a signal-transducing protein and a cytoplasmic protein. This invention also provides a method of identifying a compound capable of inhibiting specific binding between a signal-transducing protein and a cytoplasmic protein. This invention also provides a method of inhibiting the proliferation of cancer cells. This invention also provides a method of treating cancer with a composition in an amount effective to result in an amount in apoptosis of the cells. This invention also provides a method of inhibiting the proliferation of virally infected cells. This invention also provides for a method of treating a virally-infected subject with a composition in an amount effective to result in apoptosis of the cells. This invention also provides for pharmaceutical compositions.
    Type: Grant
    Filed: July 22, 1996
    Date of Patent: June 28, 2005
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Takaaki Sato, Junn Yanagisawa
  • COMPOUNDS THAT INHIBIT THE INTERACTION BETWEEN SIGNAL-TRANSDUCING PROTEINS AND THE GLGF (PDZ/DHR) DOMAIN AND USES THEREOF
    Publication number: 20030203414
    Abstract: This invention provides for a composition capable of inhibiting specific binding between a signal-transducing protein and a cytoplasmic protein. This invention also provides a method of identifying a compound capable of inhibiting specific binding between a signal-transducing protein and a cytoplasmic protein. This invention also provides a method of inhibiting the proliferation of cancer cells. This invention also provides a method of treating cancer with a composition in an amount effective to result in an amount in apoptosis of the cells. This invention also provides a method of inhibiting the proliferation of virally infected cells. This invention also provides for a method of treating a virally-infected subject with a composition in an amount effective to result in apoptosis of the cells. This invention also provides for pharmaceutical compositions.
    Type: Application
    Filed: May 17, 1999
    Publication date: October 30, 2003
    Inventors: TAKA-AKI SATO, JUNN YANAGISAWA
  • COMPOUNDS THAT INHIBIT THE INTERACTION BETWEEN SIGNAL-TRANSDUCING PROTEINS AND THE GLGF (PDZ/DHR) DOMAIN AND USES THEREOF
    Publication number: 20020058607
    Abstract: This invention provides for a composition capable of inhibiting specific binding between a signal-transducing protein and a cytoplasmic protein. This invention also provides a method of identifying a compound capable of inhibiting specific binding between a signal-transducing protein and a cytoplasmic protein. This invention also provides a method of inhibiting the proliferation of cancer cells. This invention also provides a method of treating cancer with a composition in an amount effective to result in an amount in apoptosis of the cells. This invention also provides a method of inhibiting the proliferation of virally infected cells. This invention also provides for a method of treating a virally-infected subject with a composition in an amount effective to result in apoptosis of the cells. This invention also provides for pharmaceutical compositions.
    Type: Application
    Filed: July 22, 1996
    Publication date: May 16, 2002
    Inventors: TAKAAKI SATO, JUNN YANAGISAWA